A geometric approach to comparing treatments for rapidly fatal diseases

Biometrics

Volumn 62, Issue 1, 2006, Pages 193-201

  Thall, Peter F ^a   Wooten, Leiko H ^a   Shpall, Elizabeth J ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Adaptive design; Bayesian design; Clinical trials; Competing risks; Cord blood transplantation; Simulation

Indexed keywords

BLOOD; DISEASE CONTROL;

ADAPTIVE DESIGNS; BAYESIAN DESIGN; BLOOD TRANSPLANTATION; CLINICAL TRIAL; COMPETING RISKS; CORD BLOOD; CORD BLOOD TRANSPLANTATION; FATAL DISEASE; SIMULATION; TWO-DIMENSIONAL;

BAYESIAN NETWORKS;

DISEASE TREATMENT;

ARTICLE; FATALITY; GEOMETRY; HUMAN; MEDICAL PRACTICE; PHYSICIAN; RISK ASSESSMENT; UMBILICAL CORD BLOOD;

EID: 33645090920     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/j.1541-0420.2005.00434.x     Document Type: Article

References (18)

1. Bryant J. and Day R. 1995 Incorporating toxicity considerations into the design of two-stage phase II clinical trials Biometrics 51 1372 1383
2. Conaway M. R. and Petroni G. R. 1996 Designs for phase II trials allowing for a trade-off between response and toxicity Biometrics 52 1375 1386
3. Estey E. H. Shen Y. and Thall P. F. 2000 Effect of time to complete remission on subsequent survival and disease-free survival time in AML, RAEB-t and RAEB Blood 95 72 77
4. Jennison C. and Turnbull B. W. 1993 Group sequential tests for bivariate response: Interim analyses of clinical trials with both efficacy and safety endpoints Biometrics 49 741 752
5. Kosorok M. R. Shi Y. and DeMets D. L. 2004 Design and analysis of group sequential clinical trials with multiple primary endpoints Biometrics 60 134 145
6. Kurtzberg J. Laughlin M. Graham M. L. Smith C. Olson J. F. Halperin E. C. Ciocci G. Carrier C. Stevens C. E. and Rubinstein P. 1996 Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients New England Journal of Medicine 335 157 166
7. Nelder J. A. and Mead R. 1965 A simplex method for function minimization Computer Journal 7 308
8. O'Brien P. C. 1984 Procedures for comparing samples with multiple endpoints Biometrics 40 1079 1087
9. Owen A. and Zhou Y. 1999 Safe and effective importance sampling Journal of the American Statistical Association 95 135 140
10. Pocock S. J. Geller N. J. and Tsiatis A. A. 1987 The analysis of multiple endpoints in clinical trials Biometrics 43 487 498
11. Rubinstein P. Carrier C. Scaradavou A. et al 1998 Outcomes among 562 recipients of placental-blood transplants from unrelated donors New England Journal of Medicine 339 1565 1577
12. Shpall E. J. Quinones R. Giller R. et al. 2002 Transplantation of ex vivo expanded cord blood Biology of Blood and Marrow Transplantation 8 368 376
13. Takahasi H. and Mori M. 1974 Double exponential formulas for numerical integration Publication RIMS Kyoto University 9 721 741
14. Tang D. I. Gnecco C. and Geller N. L. 1989 Design of group sequential clinical trials with multiple endpoints Journal of the American Statistical Association 84 776 779
15. Thall P. F. and Cheng S. C. 1999 Treatment comparisons based on two-dimensional safety and efficacy alternatives in oncology trials Biometrics 55 746 753
16. Thall P. F. Simon R. M. and Shen Y. 2000 Approximate Bayesian evaluation of multiple treatment effects Biometrics 56 213 219
17. Thall P. F. Sung H. G. and Estey E. H. 2002 Selecting therapeutic strategies based on efficacy and death in multi-course clinical trials Journal of the American Statistical Association 97 29 39
18. Willan A. R. and Pater J. L. 1985 Hypothesis testing and sample size for bivariate binomial response in the comparison of two groups Journal of Chronic Diseases 38 603 608